161 related articles for article (PubMed ID: 9500593)
1. Melanoma vaccines: prim and proper presentation.
Timmerman JM; Levy R
Nat Med; 1998 Mar; 4(3):269-70. PubMed ID: 9500593
[No Abstract] [Full Text] [Related]
2. Vaccines and melanoma.
Nestle FO
Clin Exp Dermatol; 2002 Oct; 27(7):597-601. PubMed ID: 12464156
[TBL] [Abstract][Full Text] [Related]
3. Melanoma peptide vaccines: from preclinical background to clinical trials.
Weber J
Curr Oncol Rep; 2000 Jan; 2(1):38-47. PubMed ID: 11122823
[TBL] [Abstract][Full Text] [Related]
4. Melanoma antigens and targets for vaccination.
Kang N; Truman H; Sanders R; Kupsch J
Br J Hosp Med; 1997 Sep 17-30; 58(6):282-6. PubMed ID: 9488805
[TBL] [Abstract][Full Text] [Related]
5. Melanoma vaccines.
Elliott B; Dalgleish A
Hosp Med; 2004 Nov; 65(11):668-73. PubMed ID: 15566059
[TBL] [Abstract][Full Text] [Related]
6. Closing in on a melanoma skin cancer vaccine.
Mayo Clin Health Lett; 2012 Oct; 30(10):4. PubMed ID: 23133855
[No Abstract] [Full Text] [Related]
7. Cancer immunotherapy. A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells.
Carreno BM; Magrini V; Becker-Hapak M; Kaabinejadian S; Hundal J; Petti AA; Ly A; Lie WR; Hildebrand WH; Mardis ER; Linette GP
Science; 2015 May; 348(6236):803-8. PubMed ID: 25837513
[TBL] [Abstract][Full Text] [Related]
8. Multiple antigen-targeted immunotherapy with alpha-galactosylceramide-loaded and genetically engineered dendritic cells derived from embryonic stem cells.
Fukushima S; Hirata S; Motomura Y; Fukuma D; Matsunaga Y; Ikuta Y; Ikeda T; Kageshita T; Ihn H; Nishimura Y; Senju S
J Immunother; 2009 Apr; 32(3):219-31. PubMed ID: 19242378
[TBL] [Abstract][Full Text] [Related]
9. Cancer immunotherapy. Neo approaches to cancer vaccines.
Delamarre L; Mellman I; Yadav M
Science; 2015 May; 348(6236):760-1. PubMed ID: 25977539
[No Abstract] [Full Text] [Related]
10. Clinical genetics. Sequencing for tailored melanoma immunotherapy.
Jones B
Nat Rev Genet; 2015 May; 16(5):259. PubMed ID: 26065036
[No Abstract] [Full Text] [Related]
11. Melanoma vaccines.
Chapman PB
Semin Oncol; 2007 Dec; 34(6):516-23. PubMed ID: 18083375
[TBL] [Abstract][Full Text] [Related]
12. Phase I/II study of treatment with dendritic cell vaccines in patients with disseminated melanoma.
Hersey P; Menzies SW; Halliday GM; Nguyen T; Farrelly ML; DeSilva C; Lett M
Cancer Immunol Immunother; 2004 Feb; 53(2):125-34. PubMed ID: 14600790
[TBL] [Abstract][Full Text] [Related]
13. Dendritic cells loaded with killed allogeneic melanoma cells can induce objective clinical responses and MART-1 specific CD8+ T-cell immunity.
Palucka AK; Ueno H; Connolly J; Kerneis-Norvell F; Blanck JP; Johnston DA; Fay J; Banchereau J
J Immunother; 2006; 29(5):545-57. PubMed ID: 16971810
[TBL] [Abstract][Full Text] [Related]
14. Dendritic cell immunizations alone or combined with low doses of interleukin-2 induce specific immune responses in melanoma patients.
Escobar A; López M; Serrano A; Ramirez M; Pérez C; Aguirre A; González R; Alfaro J; Larrondo M; Fodor M; Ferrada C; Salazar-Onfray F
Clin Exp Immunol; 2005 Dec; 142(3):555-68. PubMed ID: 16297169
[TBL] [Abstract][Full Text] [Related]
15. Vaccination for malignant melanoma: recent developments.
Jäger D; Jäger E; Knuth A
Oncology; 2001; 60(1):1-7. PubMed ID: 11150901
[TBL] [Abstract][Full Text] [Related]
16. Current status of melanoma vaccines.
Kuhn CA; Hanke CW
Dermatol Surg; 1997 Aug; 23(8):649-54; discussion 654-5. PubMed ID: 9256911
[TBL] [Abstract][Full Text] [Related]
17. Vaccines for melanoma: translating basic immunology into new therapies.
Wolchok JD; Livingston PO
Lancet Oncol; 2001 Apr; 2(4):205-11. PubMed ID: 11905765
[TBL] [Abstract][Full Text] [Related]
18. Melanoma vaccines as a therapeutic option.
Berd D
South Med J; 2000 Apr; 93(4):439-40. PubMed ID: 10798519
[No Abstract] [Full Text] [Related]
19. Melanoma vaccines: breakthrough or bust?
Sabel MS; Sondak VK
Cancer Invest; 2002; 20(7-8):1114-6. PubMed ID: 12449744
[No Abstract] [Full Text] [Related]
20. [Activation of anti-tumor cytotoxic T lymphocytes by fusion of human dendritic cells and melanoma cells].
Zhu HC; Wu SH; Huang BY; Zhu B; Gu HH; Luo XB; Xiong Z; Chen WS
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Nov; 33(11):1012-8. PubMed ID: 19060369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
